Revolution Medicines Ownership & Insider Activity

Revolution Medicines Inc

RVMDNASDAQ

$186.99

-0.70-0.37%

Últ. Act.: Oct 23, 5:36 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo Finanzas SentimientoPropiedadComparar Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 9 días de ahora en mié nov 4th, después del cierre del mercado

Revolution Medicines Ownership & Insider Activity

Revolution Medicines (RVMD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$57.0M total

Net Activity

Net Selling

Net Value (90d)

-$57.0M

Revolution Medicines Insider Transactions (Last 6 Months)

Ver todas las transacciones con información privilegiada →

Date	Insider	Title	Type	Shares	Price	Value
Sep 29, 2026	Alan B Sandler	CHIEF DEVELOPMENT OFFICER	SELL	309.000	$130.49	$922K
Sep 25, 2026	Jeff Cislini	SVP & GENERAL COUNSEL	SELL	765.000	$207.32	$159K
Sep 24, 2026	Anthony Mancini	SEE REMARKS	SELL	587.000	$117.04	$638K
Sep 22, 2026	Elizabeth M Anderson	—	SELL	5.073K	$97.08	$2.0M
Sep 18, 2026	Anthony Mancini	SEE REMARKS	SELL	1.764K	$196.94	$347K
Sep 16, 2026	Alan B Sandler	CHIEF DEVELOPMENT OFFICER	SELL	341.000	$199.24	$68K
Sep 16, 2026	Anthony Mancini	SEE REMARKS	SELL	1.774K	$199.24	$353K
Sep 16, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	5.569K	$199.24	$1.1M
Sep 16, 2026	Margaret A Horn	CHIEF OPERATING OFFICER	SELL	4.967K	$199.24	$990K
Sep 16, 2026	Mark A Goldsmith	SEE REMARKS	SELL	13.988K	$199.24	$2.8M
Sep 16, 2026	Jeff Cislini	SVP & GENERAL COUNSEL	SELL	3.366K	$199.24	$671K
Sep 16, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	4.053K	$199.24	$808K
Sep 11, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL-OPTIONS	—	$122.04	$14.9M
Sep 10, 2026	Anthony Mancini	SEE REMARKS	SELL	6.085K	$118.89	$2.8M
Sep 8, 2026	Lorence H Kim	—	SELL	17.090K	$209.82	$3.6M
Aug 31, 2026	Lorence H Kim	—	SELL	56.000K	$203.24	$11.4M
Aug 21, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	614.000	$114.62	$10.8M
Aug 21, 2026	Mark A Goldsmith	SEE REMARKS	SELL	6.000K	$106.96	$17.6M
Jun 29, 2026	Sushil Patel	—	SELL	2.625K	$112.76	$938K
Jun 24, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$93.45	$3.0M
Jun 16, 2026	Anthony Mancini	SEE REMARKS	SELL	4.615K	$156.12	$720K
Jun 16, 2026	Mark A Goldsmith	SEE REMARKS	SELL	10.020K	$156.12	$1.6M
Jun 16, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	2.157K	$156.12	$337K
Jun 16, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	2.722K	$156.12	$425K
Jun 16, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	4.175K	$156.12	$652K
Jun 11, 2026	Margaret Horn	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$94.47	$1.1M
May 26, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$93.81	$376K
Apr 27, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$83.02	$308K

Revolution Medicines Inc

Revolution Medicines Ownership & Insider Activity

Revolution Medicines Insider Transactions (Last 6 Months)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Revolution Medicines Ownership & Insider Activity

Revolution Medicines Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch